MedPath
NMPA Approval

Ranitidine Hydrochloride Capsules

国药准字H33020210

September 10, 2024

Drug Information

盐酸雷尼替丁胶囊

胶囊剂

0.15g(按C13H22N4O3S计)

化学药品

September 10, 2024

Company Information

Applicant Company

浙江省新昌县羽林街道新昌大道东路800号

Manufacturing Company

浙江省新昌县羽林街道新昌大道东路800号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.